INTELLIGENT BIO SOLUTIONS INC. Impairment of Intangible Assets, Finite-lived
INTELLIGENT BIO SOLUTIONS INC. (INBS) reported Impairment of Intangible Assets, Finite-lived of $0 for the 9-month period ending 2025-03-31, per its 10-Q filed 2025-05-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ImpairmentOfIntangibleAssetsFinitelived · last filed 2025-05-13
- INTELLIGENT BIO SOLUTIONS INC. impairment of intangible assets, finite-lived for the quarter ending 2025-03-31 was $0.00.
- INTELLIGENT BIO SOLUTIONS INC. impairment of intangible assets, finite-lived for the quarter ending 2024-12-31 was $0.00.
- INTELLIGENT BIO SOLUTIONS INC. impairment of intangible assets, finite-lived for the quarter ending 2024-09-30 was $0.00.
| Period end | Impairment of Intangible Assets, Finite-lived 3 month | Impairment of Intangible Assets, Finite-lived 6 month | Impairment of Intangible Assets, Finite-lived 9 month |
|---|---|---|---|
| 2025-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-05-13 | $0.00 derived: sum of 2 quarters · filed 2025-05-13 | $0.00 10-Q · filed 2025-05-13 |
| 2024-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-02-13 | $0.00 10-Q · filed 2025-02-13 | |
| 2024-09-30 | $0.00 10-Q · filed 2024-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |